cjc 1295 and ipamorelin
Technical Overview
CJC-1295 (No DAC) is a modified growth hormone releasing hormone (GHRH) analog designed for research related to pituitary stimulation mechanisms, while Ipamorelin is a selective pentapeptide studied for its interaction with growth hormone secretagogue receptors (GHS-R). When combined, these compounds are frequently utilized in peptide research protocols exploring synergistic signaling behavior under controlled experimental conditions.
The blend is typically synthesized using established peptide manufacturing methods and purified through HPLC to achieve high analytical purity suitable for research and assay applications.
Specifications
Compound Name: CJC-1295 (No DAC)
Available Strengths: 5/5 mg · 10/10 mg
Format: Research Peptide Blend
Appearance: Lyophilized Peptide Powder
Purity: ≥ 99% (HPLC Verified)
Storage: −20°C recommended
Notice
This compound is provided strictly as a reference reagent for scientific and laboratory investigation.




Reviews
There are no reviews yet.